Easton Pharmaceuticals Announces Receipt of all Technical Documents from Biolyse Pharma for Filing of a Marketing Authorization Dossier Life Science Investing
Ocular Therapeutix™ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZA™ Biotech Investing
InspireMD Announces CGuard(TM) Embolic Prevention System Commercialization Approval in Russia Medical Device Investing
Dynavax Receives Complete Response Letter from U.S. FDA for Biologics License Application for HEPLISAV-B Biotech Investing
Thermo Fisher Scientific Submits Premarket Approval Application to FDA for Next-Generation Sequencing-Based Oncology Test Biotech Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
